Incidence of hepatitis A virus infection among an Italian military population. 1994

P M Matricardi, and R D'Amelio, and R Biselli, and M Rapicetta, and A Napoli, and P Chionne, and T Stroffolini
Laboratories of Virology and Epidemiology, Istituto Superiore di Sanità, Rome, Italy.

In 1990, a prospective serological survey to estimate the rate of clinical and inapparent infection with hepatitis A virus (HAV) was performed in a cohort of 1,268 soldiers, 18-24 years old, during an 8 month period in the Campania region in Italy. At the time of enrollment 318 (25%) of the 1,268 soldiers were positive for total antibodies to HAV (anti-HAV). None of them was positive for IgM anti-HAV. Among the 950 susceptible subjects who were followed up for 8 months, eight (0.8%) later seroconverted to anti-HAV positivity. This figure corresponds to an incidence of 1.3/100 person/years (eight seroconversions during 633.3 years of observation). There were two clinical (with presence of IgM-anti-HAV) and six inapparent infections. The clinical/subclinical HAV ratio was 1:3. These findings indicate that the risk of HAV infection among soldiers residing in this area is not negligible.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008889 Military Personnel Persons including soldiers involved with the armed forces. Air Force Personnel,Armed Forces Personnel,Army Personnel,Coast Guard,Marines,Navy Personnel,Sailors,Soldiers,Submariners,Military,Force Personnel, Air,Personnel, Air Force,Personnel, Armed Forces,Personnel, Army,Personnel, Military,Personnel, Navy,Sailor,Soldier,Submariner
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D006506 Hepatitis A INFLAMMATION of the LIVER in humans caused by a member of the HEPATOVIRUS genus, HUMAN HEPATITIS A VIRUS. It can be transmitted through fecal contamination of food or water. Hepatitis, Infectious,Infectious Hepatitis,Hepatitides, Infectious,Infectious Hepatitides
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D035922 Hepatitis A Antibodies Antibodies to the HEPATITIS A ANTIGENS including antibodies to envelope, core, and non-structural proteins. Hepatitis A Virus Antibodies,Anti-HAV,Anti HAV,Antibodies, Hepatitis A

Related Publications

P M Matricardi, and R D'Amelio, and R Biselli, and M Rapicetta, and A Napoli, and P Chionne, and T Stroffolini
October 1997, Italian journal of gastroenterology and hepatology,
P M Matricardi, and R D'Amelio, and R Biselli, and M Rapicetta, and A Napoli, and P Chionne, and T Stroffolini
March 2021, Journal of immunoassay & immunochemistry,
P M Matricardi, and R D'Amelio, and R Biselli, and M Rapicetta, and A Napoli, and P Chionne, and T Stroffolini
December 2020, Scientific reports,
P M Matricardi, and R D'Amelio, and R Biselli, and M Rapicetta, and A Napoli, and P Chionne, and T Stroffolini
March 1996, Thorax,
P M Matricardi, and R D'Amelio, and R Biselli, and M Rapicetta, and A Napoli, and P Chionne, and T Stroffolini
August 2020, Journal of viral hepatitis,
P M Matricardi, and R D'Amelio, and R Biselli, and M Rapicetta, and A Napoli, and P Chionne, and T Stroffolini
October 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
P M Matricardi, and R D'Amelio, and R Biselli, and M Rapicetta, and A Napoli, and P Chionne, and T Stroffolini
August 1991, Journal of medical virology,
P M Matricardi, and R D'Amelio, and R Biselli, and M Rapicetta, and A Napoli, and P Chionne, and T Stroffolini
January 2021, Annali di igiene : medicina preventiva e di comunita,
P M Matricardi, and R D'Amelio, and R Biselli, and M Rapicetta, and A Napoli, and P Chionne, and T Stroffolini
April 1983, The Japanese journal of experimental medicine,
P M Matricardi, and R D'Amelio, and R Biselli, and M Rapicetta, and A Napoli, and P Chionne, and T Stroffolini
January 2022, Southern African journal of HIV medicine,
Copied contents to your clipboard!